1 - ANALYSIS
Fundamental analysis is the first step to determine the clinical and commercial success of a new life science product. We use our proprietary “7Ps” method to assess the impact on e.g. the Patient, Prescriber, and Payer.
2 - VALUATION
The second step is to translate the commercial potential of an emerging product/company into financial forecasts and a current valuation. We take into account the future cash flows and adjust these for clinical, regulatory and market risks.
3 - RESEARCH
The final step is to share the progress of the company. We provide regular, comprehensive research reports that provide an independent view to stakeholders, shareholders and other interested parties.